Hao Yang

6PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targetsPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 29, 2026
EGFR-dependent delivery of phosphorylated IGFBP3 by cancer stem cells drives chemotherapy resistance in colorectal cancer.

|Apr 24, 2026
ASPP2 inhibits hepatocellular carcinoma growth by regulating cuproptosis via mitochondrial protein lipoylation.

|Nov 11, 2025
Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer.

Xiyu Liu, Zijun Mao, Jinglin Yang

|Apr 18, 2024
Ovarian serous carcinoma with stomach metastasis: a rare case report and literature review.

Jia-Li Hu, Zhao-Jiao Guo, Chun Wang

|Nov 09, 2022
TNFα-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity.

Hao Yang, Xiaoping Zhao, Jianjun Liu

|Jun 16, 2022
Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.

Yitian Dai, Yuping Liu, Jingyi Li

Pageof 1

Frequent Collaborators

2 joint publications

Liu Liu

2 joint publications

Gang Huang

2 joint publications

Beibei Liang

1 joint publications

Jian Zhao